Transcript Slide 1
Economic Considerations Lynn Webster M.D. Lifetree Clinical Research and Pain Clinic Salt Lake City, Utah Economic Factors • Site of Service – Hospital Inpatient, Hospital Outpatient, ASC, Office • Management Cost – Cost of drugs, refill kits and office overhead • Management Reimbursement – Drugs – Cognitive skills Payment by Site of Service: Trial Outpatient Hospital Trial Code Description Facility Pymt MD Pymt w/Fix MD Pymt w/o Fix 62319 Injection, including catheter placement, cont infusion $485 $92 $71 $485 $92 $71 Total Inpatient Hospital Trial Description DRG Facility Pymt MD Pymt w/Fix MD Pymt w/o Fix Medical back problems w/MCC 552 $4487 $92 $71 $4487 $92 $71 Total CPT Copyright 2008 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Changes to the Hospital Outpatient Prospective Payment System and FY 2010 Payment Rates. Federal Register Display Date: October 30, 2009 Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2010. Federal Register Display Date: October 30, 2009 The drug used for the trial is included in the DRG for Inpatient Trials. For outpatient hospital trials, Lioresal and Prialt are reimbursed separately, Infumorph is packaged in the APC payment. Payment by Site of Service: Implant Outpatient Hospital Implant Code Description Facility Pymt MD Pymt w/Fix MD Pymt w/o Fix 62350 Catheter Implant *multiple surg $1443 $184 $146 $13305 $385 $306 $14748 $569 $452 reduction is reflected 62362 Programmable Pump Implant Total Inpatient Hospital Implant Description DRG Facility Pymt MD Pymt w/Fix MD Pymt w/o Fix Peripheral/Cranial and Other Nervous System W/CC or Peripheral Neurostimulator 41 $11967 $184 $385 $146 $306 $11967 $569 $452 Total CPT Copyright 2008 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Changes to the Hospital Outpatient Prospective Payment System and FY 2010 Payment Rates. Federal Register Display Date: October 30, 2009 Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2010. Federal Register Display Date: October 30, 2009 The DRG assignment varies depending on diagnoses and severity of illness (MCC or CC). For illustration above a pain disorder diagnoses was used. Payment by Site of Service Refill Programming and Analysis Outpatient Hospital Refill Code Description 62368 95990 95991 J2275 Total Facility Pymt Pump Programming and Analysis $171 Refill – NonPhys NA Refill – Physician $127 Morphine, 10 mg N/A Physician Office Refill MD Pymt w/Fix MD Pymt w/o Fix $37 $28 $64 $37 $56 Code Description MD Pymt w/Fix MD Pymt w/o Fix 62368 Pump Programming and Analysis $54 $43 95990* Refill – Non-Phys $75 $56 95991 Refill – Physician $93 $79 J2275 Morphine, 10 mg $14 $28 Total $298 $74 $161 $56 •Fee not established for 95990 in facility Totals calcuated using MD Refill For illustration, Infumorph 50 mg used for calculating payment http://www.cms.hhs.gov/McrPartBDrugAvgSalesPrice/01a1_2009aspfiles.asp Refill kits are used in both sites of services and are included in the payment reflected above CPT Copyright 2008 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Changes to the Hospital Outpatient Prospective Payment System and FY 2010 Payment Rates. Federal Register Display Date: October 30, 2009 $136 Drug Reimbursement Methods • • • • AWP ASP Fee Schedules Rebate Programs Medicare Administrative Contractor (MAC) Drug Reimbursement • All contractors instructed to utilize ASP pricing for commercially prepared drugs used in infusion pumps – http://www.cms.hhs.gov/McrPartBDrugAvgSalesPrice/01a19_2010aspfiles.asp • Because of some confusion, a couple MACs still paying at 95% of Average Wholesale Price (AWP) • Compounded Drugs are Paid at MAC discretion – Payment Varies – Coding/reporting requirements vary Current ASP* Payment Amounts Facility Reimbursement = ASP + 5% 10/1/2010 10/1/2010 Difference HCPCs Code Drug Dosage J0475 Baclofen 10 MG injection 10 MG $203.93 $200.08 $3.85 J0476 Baclofen intrathecal trial 50 MCG $73.15 $71.77 $1.37 J2275 Morphine sulfate injection 10 MG $2.42 $2.37 $0.05 J2278 Ziconotide injection 1 MCG $6.61 $6.48 0.3 *Average Sales Price Cost Physician Office Reimbursement = ASP + 6% Current AWP* Amounts • • • • Baclofen 10 mg $215.18 Baclofen 50 mcg $ 79.80 Morphine Sulfate 10mg $4.39 approx Ziconitide only priced at ASP *Average Wholesale Price IT Reimbursement • Industrial Claims – Each state’s Industrial Commission sets the fee schedule • Some states pay at invoice plus ~15% • Private Payers – Most use the Medicare ASP + 6% fee schedule • Noridian Medicare – J3490 code – Pay from invoice with no additional payment allowed IT Therapy Costs LOW $ $ $ HIGH $ $ IT Morphine •Average dose 6 mcg/day in 20-mL Medtronic pump •ASP + 6% = $2.83/10 mg $ $ $ $ IT Prialt •Average dose 4 mcg/day in 20-mL Medtronic pump •ASP + 6% = $6.51/mcg Oral Therapy Costs LOW $ $ $ HIGH $ $ Methadone® 10 mg QID Oxycodone® 15mg QID Gabapentin® 400 mg QID Desipramine® 10mg TID Trazodone® 50mg QHS $ $ $ $ Oxycontin® 80 mg TID Percocet® 10/325 mg 8x day Lyrica® 150 mg BID Cymbalta® 60 mg QD Klonopin® 1 mg BID Ambien® CR 12.5 mg QHS Cost Comparison of 2 Intrathecal Medications to an Oral Brand Name Medication Regimen and an Oral Generic Medication Regimen $36,000.00 $33,000.00 $30,000.00 Cost ( in Dollars ) $27,000.00 $24,000.00 $21,000.00 $18,000.00 $15,000.00 $12,000.00 $9,000.00 $6,000.00 $3,000.00 $0.00 0 1 2 3 4 5 6 7 8 9 10 11 Time ( in Months / 30 Days ) Intrathecal Prialt Intrathecal Morphine Deer and Smith, et al. Manuscript in Progress Oral Brand Name Regimen Oral Generic Regimen 12 Economic Considerations • IT therapy can be less expensive than using oral medications • Reimbursement depends on payer and site of service • Drug invoice pricing may not provide payment for handling and acquisition Economic Considerations • The Neuromodulation Therapy Access Foundation (NTAC) is working with multiple organizations to provide appropriate payment for all aspects of pump therapy – Palmetto GBA recently implemented fee schedule that replaces invoice only methodology (California, Nevada, Hawaii) – Allows for fee schedule to cover drug and separate compounding fee • Thanks to Drs Schwachmann, Helm and William Stuart PharmD